Cosmax NBT
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Cosmax NBT makes health supplements, vitamins, probiotics, and functional nutrition products, that consumers take to support their wellbeing.
It supplies these products to brand-owner customers across dozens of countries, acting as a contract developer and manufacturer rather than a consumer-facing brand itself. Listed on KOSDAQ, Korea's tech and small-cap board, the company earns the majority of its revenue from overseas markets, with production facilities in Korea and Australia and a sales operation in the United States.
Summary is AI-generated and may contain errors · figures from DART filings
The company claims to be the first Korean health-supplement firm to build a multi-country production network, with manufacturing entities in Korea and Australia and a sales entity in the US.
Cosmax NBT in five facts
What does Cosmax NBT do?
Cosmax NBT makes health supplements, vitamins, probiotics, and functional nutrition products, that consumers take to support their wellbeing.
Where is Cosmax NBT listed and in which sector?
Cosmax NBT (Korean name: 코스맥스엔비티) trades under KRX code 222040 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Cosmax NBT?
Its market capitalisation was US$78.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Cosmax NBT's latest annual revenue and operating profit?
For fiscal year 2025, Cosmax NBT reported revenue of US$217M, operating profit of US$3M and a net loss of US$11.4M, per its annual report on DART (data retrieved from DART on 2026-09-18). Revenue was down 9.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-18
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Decision to guarantee a third party's debtOct 16
- [Amended] Decision to guarantee a third party's debtSep 9
- Operating results (consolidated) (preliminary) (fair disclosure)
Cosmax NBT filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$71.9M (+35.2% year on year), operating profit of US$5.96M (+236.2% year on year) and net income of US$21.3M (from a loss a year earlier).
Earnings · Aug 7 - Rights offering (paid-in capital increase) decision (subsidiary)
Cosmax NBT Co., Ltd.'s Australian subsidiary, COSMAX NBT AUSTRALIA PTY. LTD., carried out a shareholder rights offering of 10,000,000 new common shares at US$0.70 (AUD 1) per share on July 15, 2026, raising US$7M (AUD 10,000,000) in working capital.
Capital raise · Jul 15 - Decision to acquire shares/equity in another company
Cosmax NBT disclosed an acquisition of COSMAX NBT AUSTRALIA PTY. LTD., worth US$7M.
M&A · Jul 15 - Completion report on merger, etc. (merger)M&A · Jun 30
- Operating results (consolidated) (preliminary) (fair disclosure)
Cosmax NBT filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$64.1M (+29.2% year on year), operating profit of US$7.06M (+1080.1% year on year) and net income of US$6.29M (from a loss a year earlier).
Earnings · May 7 - [Attachment amended] Material event report (merger)M&A · Apr 13
- Material event report (merger)M&A · Apr 10
- Decision to acquire shares/equity in another company
Cosmax NBT disclosed an acquisition of Cosmax NS Co., Ltd., worth US$2.53M.
M&A · Mar 17 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Cosmax NBT updated its previously filed consolidated results for FY2025: revenue of US$195M (−9.6% year on year), operating profit of US$2.72M (−59.6% year on year) and a net loss of US$10.2M.
Earnings · Mar 11 · 2 versions